1998
DOI: 10.1016/s0016-5085(98)84159-0
|View full text |Cite
|
Sign up to set email alerts
|

Fas ligand mediated killing by intestinal intraepithelial lymphocytes: Participation in graft-versushost disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

1998
1998
2007
2007

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…Furthermore, the inhibition of IFN-g (37), TNF-a (64), IL-1 (63), or NO (65) can reduce GI tract histopatholog y in animals with GVHD. In contrast, CTL effectors do not appear to play a dominant role in experimental GVHD of the GI tract (17,(66)(67)(68)(69)(70), despite the ability of intraepithelial lymphocytes to induce Fas-mediated apoptosis of host-type tumor cells (71).…”
Section: Phase Three: Inflammatory Effectorsmentioning
confidence: 99%
“…Furthermore, the inhibition of IFN-g (37), TNF-a (64), IL-1 (63), or NO (65) can reduce GI tract histopatholog y in animals with GVHD. In contrast, CTL effectors do not appear to play a dominant role in experimental GVHD of the GI tract (17,(66)(67)(68)(69)(70), despite the ability of intraepithelial lymphocytes to induce Fas-mediated apoptosis of host-type tumor cells (71).…”
Section: Phase Three: Inflammatory Effectorsmentioning
confidence: 99%
“…Mice deficient in Fas (i.e., lpr mice) were described as a result of retrotransposon insertion in the Fas locus, and have a phenotype similar to that of gld mice (i.e., lymphoproliferative disease) (Watanabe-Fukunaga et al, 1992). The lpr mice have been an important tool in understanding the role of Fas±FasL interactions in regulation of viral infections, autoimmune diseases, and immunological privilege (Green and Ware, 1997;Griffith and Ferguson, 1997;Lin et al, 1998).…”
Section: Introductionmentioning
confidence: 99%
“…The ability of IEL to induce the cytotoxic killing of human Jurkat T cells (primarily through a Fas-mediated mechanism) has been previously described (32 Figure 3). As shown in Figure 3 …”
Section: Introductionmentioning
confidence: 72%